Randox RX Imola Analyser with ISE, Catalog Numbers RX4900, RX4900R

FDA Device Recall #Z-2013-2021 — Class II — April 28, 2021

Recall Summary

Recall Number Z-2013-2021
Classification Class II — Moderate risk
Date Initiated April 28, 2021
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Randox Laboratories Ltd.
Location Crumlin (North)
Product Type Devices
Quantity 50 kits

Product Description

Randox RX Imola Analyser with ISE, Catalog Numbers RX4900, RX4900R

Reason for Recall

An issue was identified where the software froze during processing of commands, which resulted in no results displayed.

Distribution Pattern

US Nationwide Distribution and Puerto Rico.

Lot / Code Information

GTIN 05055273206104, Serial Numbers: 7201-0423 7201-0417 7201-0353 7201-0776 7201-0367 7201-0921 7201-0982 7201-0977 7201-0970 7201-0950 7201-0924 7201-0919 7201-0901 7201-0849 7201-0827 7201-0799 7201-0801 7201-0768 7201-0606 7201-0562 7201-0535 7201-0531 7201-0381 7201-0112 7201-0231 7201-0275 7201-0299 7201-0319 7201-0343 7201-0348 7201-0391 7201-0514 7201-0515 7201-0540 7201-0605 7201-0616 7201-0840 7201-0533 7201-0932 7201-0943 7201-0513 7201-0482 7201-0960 7201-0882 7201-0434 7201-0607 7201-0768 7201-0961 7201-0980 7201-0994

Other Recalls from Randox Laboratories Ltd.

Recall # Classification Product Date
Z-2425-2024 Class II RX Series CYSC- Cystatin C Reagent -Intended fo... Jun 7, 2024
Z-1786-2024 Class III Evidence MultiSTAT with software v 3.7-Analyzer... Apr 5, 2024
Z-1759-2024 Class II Clinical Chemistry Calibration Serum (Catalog n... Mar 5, 2024
Z-1328-2024 Class II Liquid Protein Calibrators. C3 and Haptoglobin ... Mar 1, 2024
Z-1369-2024 Class II Cystatin C Calibrator - In vitro diagnostic (IV... Feb 14, 2024

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.